Irma Alert and The Digital Immune System: Winners of the Flemingsberg Science Award STARTUP 2024
Sweden’s children and youth are not doing well. Mental health issues, increasing neuropsychiatric disorders, and sociocultural confusion, partly caused by social media, are on the rise. As a result, the level of knowledge among young people is declining, with reading comprehension and mathematics being particularly problematic areas. Irma Alert, the winner of the Flemingsberg Science Award, wants to change this.
“I am developing a digital environment aimed at taking better care of Sweden’s youth and which can be seen as a contrast to the social environments that to some extent create pressure on young people today. There, they will be able to get help, primarily through nudging and self-help methods, to feel better and thus perform better. It is a way to future-proof Sweden.” – Irma Alert, founder of The Digital Immune System.
“It’s a fact that psychological problems in children have doubled since 1980. Today’s society is hopelessly behind on monitoring and understanding the youth, years behind, and this needs to be changed. A backpack full of basic existing therapeutical methods combined with innovative features can be the gamechanger that the society needs. An experienced founder and an advisory board with broad competence can make this challenging idea fly!” – Johnny Högberg, CEO Flemingsberg Science Foundation.
See the full interview with Irma Alert.
Chris Heister: “Everyone who has made this journey feels as though they’re fighting the system a bit.”
Even if Chris Heister shifts down a gear when she leaves her role as council leader in Stockholm, she is unlikely be drawing on her pension any time soon. The class journey she has made from growing up in a countryside idyll, north of Stockholm, has given her a momentum that continually drives her forward.
Evren Alici set to make cancer a liveable illness
A recent study could pave the way to treating a type of bone marrow cancer. The aim is to transform the cancer from being incurable to a disease that it is possible to live with. The research behind the study was conducted in Evren Alici’s group at Campus Flemingsberg.
Karin Mellström: “Co-operation is the key to success”
After 10 years as a start-up, CellProtect Nordic Pharmaceuticals has taken a major step forward. Our patient and careful work is now bearing fruit, explains Karin Mellström, CEO and founder. Looking back on her career, she sums it up by saying: “I’d never been bored for a second!”
Matti Sällberg: “Vital to contribute facts to the debate”
During the course of the pandemic, he has appeared on an almost daily basis in the morning papers or on the TV news. Matti Sällberg fast became an expert the media called for help explaining everything from vaccine development to the spread of infection.
